Breaking
Recovery Mode

US Obesity-Linked Cancer Deaths Surge Over Three Decades

A modern radiotherapy machine in a hospital setting used for cancer treatment.
A modern radiotherapy machine in a hospital setting used for cancer treatment. Photo: Jo McNamara/Pexels

According to United States statistics, fatalities from weight-related malignancies have more than doubled over the last thirty years. The Global Burden of Disease 2023 study shows that cancer deaths associated with a BMI of 25 or above grew by 104.2%, jumping from 23,236 cases in 1990 to 47,450 in 2023.

Digantkumar Patel, MD, of the Springfield Clinic in Illinois, reported these findings at the ObesityWeek annual meeting. He noted that while the link between obesity and cancer is well-known, there’s less data on how the burden of these cancers has changed over time.

Sharp Rises in Specific Cancers

Among the 12 cancers associated with high BMI, liver, pancreatic, and uterine cancers saw the fastest growth between 1990 and 2023. Liver cancer deaths increased by 566%, pancreatic by 487%, and uterine by 193%.

Despite these sharp increases, colorectal cancer remained the leading cause of high BMI-related cancer deaths in 2023, with 11,161 deaths, a 53% rise since 1990. Deaths also increased for other cancers, including thyroid, multiple myeloma, kidney, leukemia, ovarian, gallbladder/biliary tract, non-Hodgkin lymphoma, and breast cancer.

Shifting Mortality Rankings

The rankings of these cancers by mortality shifted significantly during the study period. Liver cancer moved from eighth to second place, uterine cancer from fifth to third, and pancreatic cancer from 11th to seventh. Breast cancer dropped from second to fourth, kidney cancer from third to fifth, and leukemia from fourth to sixth. Thyroid cancer remained in 12th place.

The disability burden from these cancers also increased. Disability-adjusted life years (DALYs) nearly doubled, rising 97.4% from 560,000 to 1.11 million. Years lived with disability spiked 129.5%, from 36,997 to 84,892.

Geographic and Demographic Variations

Adults aged 55 to 79 bore the brunt of the burden, accounting for 71.3% of all high BMI-related cancer DALYs in 2023. The heaviest concentration was among those aged 65 to 69. In adults 70 and older, DALYs surged by 615% for liver cancer and 655% for pancreatic cancer.

Among females aged 15 to 39, uterine cancer DALYs rose 220%. This is concerning as it suggests the growing burden is not limited to older adults, Patel said.

Geographically, age-standardized death rates increased in 37 states, led by those in the South. West Virginia, Kentucky, and Mississippi recorded the highest death rates in 2023. The steepest increases since 1990 occurred in Oklahoma (+43%), West Virginia (+39%), New Mexico (+36%), and Tennessee (+36%). Conversely, the largest declines were seen in Washington, D.C. (-26%), New Jersey (-18%), and New York (-17%).

Patel suggested that cancer prevention strategies should be tailored to different regions rather than using a one-size-fits-all approach. He also noted the need for research to examine disparities by sex and race and to model projections through 2060 to account for the expanding use of modern obesity treatments, including GLP-1 medications.

cancer health medicine research weight
Zoe Cooper

Leave a Reply

Your email address will not be published. Required fields are marked *